Your browser doesn't support javascript.
loading
Partial response in hairy cell leukemia with vemurafenib despite early discontinuation due to agranulocytosis.
Boilève, Alice; Contejean, Adrien; Grignano, Éric; Dupin, Nicolas; Chouchana, Laurent; Bouscary, Didier; De Witasse-Thezy, Thibault.
Affiliation
  • Boilève A; Département de Médecine Oncologique, Gustave Roussy, Université Paris-Saclay, Villejuif.
  • Contejean A; Service d'hématologie, Hôpital Cochin, Assistance Publique Hôpitaux de Paris.
  • Grignano É; Service d'hématologie, Hôpital Cochin, Assistance Publique Hôpitaux de Paris.
  • Dupin N; Faculté de Médecine Sorbonne Paris Cité, Université Paris Descartes.
  • Chouchana L; Service d'hématologie, Hôpital Cochin, Assistance Publique Hôpitaux de Paris.
  • Bouscary D; Faculté de Médecine Sorbonne Paris Cité, Université Paris Descartes.
  • De Witasse-Thezy T; Faculté de Médecine Sorbonne Paris Cité, Université Paris Descartes.
Anticancer Drugs ; 31(2): 196-198, 2020 02.
Article in En | MEDLINE | ID: mdl-31205066
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Hairy Cell / Withholding Treatment / Agranulocytosis / Vemurafenib Type of study: Prognostic_studies Limits: Adult / Female / Humans Language: En Journal: Anticancer Drugs Journal subject: ANTINEOPLASICOS Year: 2020 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Hairy Cell / Withholding Treatment / Agranulocytosis / Vemurafenib Type of study: Prognostic_studies Limits: Adult / Female / Humans Language: En Journal: Anticancer Drugs Journal subject: ANTINEOPLASICOS Year: 2020 Type: Article